Preclinical toxicology and safety pharmacology of the first-in-class GADD45B/MKK7 inhibitor and clinical candidate, DTP3. Breadcrumbs UL Home Research Publications Year of Publication 2019 Journal Toxicology Reports DOI 10.1016/j.toxrep.2019.04.006